#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paroxysmal nocturnal haemoglobinuria Gastric cancer Aplastic anaemia Alternating hemiplegia of childhood Medullary thyroid cancer Thermal burn Small cell lung cancer recurrent Ovarian cancer stage III Stress cardiomyopathy Pyruvate dehydrogenase complex deficiency Liposarcoma metastatic Non-renal cell carcinoma of kidney Von Willebrand's disease Univentricular heart Lymphoma More trials…

    Learn about Rare Diseases

    Lymphangiosarcoma – Trials in Disease Alexander disease Mastocytosis – Life with Disease Leiomyosarcoma metastatic – Life with Disease Myxofibrosarcoma Marfan’s syndrome – Treatment Cytokine release syndrome – Treatment Indolent systemic mastocytosis – Diagnostics Gastrointestinal stromal tumour – Treatment Medulloblastoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZIGAKIBART Iberdomide Tipiracil Hydrochloride BENZYLPENICILLIN POTASSIUM Aztreonam Hydralazine Hydrochloride Avalglucosidase Alfa Ebastine Cebsulfase Alfa Mometasone Furoate Doxycycline Hyclate Berzosertib Sasanlimab Ravulizumab Ampreloxetine Belzupacap Sarotalocan RIVASTIGMINE Efmoroctocog Alfa Lucerastat Digoxin Immune Fab (Ovine) More therapies…

    Learn about Your Condition

    Oropharyngeal cancer recurrent Acarodermatitis Paget's disease of the vulva Hysterectomy Arthroscopy Non-Hodgkin's lymphoma Cachexia Type IIa hyperlipidaemia Bone sarcoma Cholangitis sclerosing Niemann-Pick disease Delirium Anaemia of pregnancy ROHHAD syndrome Ewing's sarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer

  • Study of WSD0922-FU for Patients with Advanced Non-Small Cell Lung Cancer and C797S Mutation After Osimertinib Treatment

    Recruiting

    2 1 1
    France

  • Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pembrolizumab
    • SIGVOTATUG VEDOTIN
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Study Comparing Nivolumab and Relatlimab with Chemotherapy to Pembrolizumab with Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer recurrent
    • Non-small cell lung cancer stage IV
    • Non-small cell lung cancer
    Investigated Drugs:
    • Relatlimab
    • Pemetrexed Disodium
    • Carboplatin
    Austria Belgium Denmark France Germany Ireland +6

  • Study Comparing Tepotinib to Standard Treatment for Patients with Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Tepotinib
    • Bevacizumab
    • Atezolizumab
    France

  • Study on Visugromab with Pembrolizumab, Pemetrexed, and Carboplatin for First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • VISUGROMAB
    • Pemetrexed Disodium
    • Carboplatin
    Bulgaria Germany Italy Poland Romania Spain

  • Study comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Alectinib Hydrochloride
    • Nvl-655
    Austria Belgium Czechia Denmark France Germany +7
Previous Page
1 … 5 6 7 8 9 … 54
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!